We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.
ARTICLE · 10 MARCH 2015
PTAB Sides With Petitioner In Pharmaceutical Inter Partes Reviews
Brinks Gilson & Lione
The Patent Trial and Appeal Board ("PTAB") recently sided with petitioner BioMarin Pharmaceutical in three inter partes review proceedings involving Genzyme’s enzyme therapy product Myozyme®.
United StatesIntellectual Property










